Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:Switzerland
|
| gptkbp:developedBy |
IL-2 based therapeutics
|
| gptkbp:focusesOn |
gptkb:cancer
immunotherapy |
| gptkbp:foundedIn |
2017
|
| gptkbp:founder |
Andreas Katopodis
Onur Boyman |
| gptkbp:headquartersLocation |
Basel
|
| https://www.w3.org/2000/01/rdf-schema#label |
Anaveon
|
| gptkbp:website |
https://www.anaveon.com/
|
| gptkbp:bfsParent |
gptkb:Syncona
|
| gptkbp:bfsLayer |
7
|